Every Form 4 that Axon Enterprise (AXON) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AXON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AXON filings page.
AXON ENTERPRISE, INC. (AXON) reported that Chief Accounting Officer Jennifer H. Mak had 155.674 shares of common stock withheld on August 31, 2026 to pay tax liability arising from the vesting of restricted stock units, at a reference price of $566.56 per share. After this tax-withholding disposition, she directly holds 13,600.294 shares of Axon common stock, and no Rule 10b5-1 trading plan is reported.
AXON ENTERPRISE, INC. (AXON) reported that Chief Revenue Officer Cameron Brooks had 734.82 shares of common stock withheld on August 31, 2026 to pay tax liability arising from the vesting of restricted stock units. The shares were valued at $566.56 per share, and Brooks now directly holds 67,246.113 shares.
AXON ENTERPRISE, INC. (AXON) reported that officer Elizabeth Reid Coughlin, Chief Human Officer, had 479.268 shares of common stock withheld on August 31, 2026 to satisfy tax liability from the vesting of restricted stock units. The shares were valued at $566.56 per share, and she now directly holds 40,362.565 shares of AXON common stock. No Rule 10b5-1 trading plan is reported.
AXON ENTERPRISE, INC. (AXON) reported that Chief Legal Officer Isaiah Fields had 763.159 shares of common stock withheld on August 31, 2026 to satisfy tax liability from the vesting of restricted stock units. These shares were disposed of at a reported value of $566.56 per share, leaving him with 57,280.855 shares held directly.
AXON ENTERPRISE, INC. (AXON) reported that its president, Joshua Isner, sold a total of 16,775 shares of common stock on August 31, 2026. The 28 open-market sale transactions were executed at weighted average prices generally between about $561 and $595 per share, and were effected pursuant to a Rule 10b5-1 trading plan adopted on June 1, 2026. The shares sold were issued upon settlement of vested restricted stock units.
AXON ENTERPRISE, INC. (AXON) reported that its CPO & CTO, Jeffrey C. Kunins, executed multiple open-market sales of 9,605 shares of common stock on August 21, 2026. The sales, at prices around $605.77–$635.02 per share, were effected under a Rule 10b5-1 trading plan and involved shares issued upon settlement of vested restricted stock units. Following these transactions, Kunins is reported to indirectly own 86,268 shares through an LLC of which he is the sole member.
AXON ENTERPRISE, INC. executive Jeffrey C. Kunins reported equity compensation and related tax withholding activity. On August 16, 2026, he acquired 20,618 shares of common stock tied to a certified fourth tranche of performance-based restricted stock units under the 2024 eXponential Stock Plan and a supplemental grant of 3,753 shares, both at $0.00 per share. On August 13, 2026, 6,232.647 shares were disposed at $615.59 per share, representing shares withheld to settle tax liability from RSU vesting. He also reports 86,268 shares held indirectly through an LLC of which he is the sole member.
AXON ENTERPRISE, INC. president Joshua Isner reported equity compensation activity. On August 16, 2026 he acquired 67,910 performance-based restricted stock units (XSUs) tied to a tranche under the 2024 eXponential Stock Plan whose performance conditions were certified, which will vest on December 1, 2026 and then be subject to a minimum holding period. He also received a supplemental equity grant of 14,218 shares. On August 13, 2026, 15,704.08 shares were withheld at $615.59 per share to settle tax liabilities from vesting restricted stock units.
AXON ENTERPRISE, INC. reported that COO & CFO Brittany Bagley had two equity-related transactions in company common stock. On August 16, 2026, she acquired 30,560 performance-based restricted stock units (XSUs) for which the fourth tranche’s performance conditions were certified as met; this tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding shares used for taxes. On August 13, 2026, 8,708.157 shares were disposed at $615.59 per share, representing shares withheld to settle her tax liability from vesting restricted stock units.
AXON ENTERPRISE, INC. reported that Chief Accounting Officer Jennifer H. Mak acquired 3,906 shares of common stock through settlement of performance-based restricted stock units (XSUs). These XSUs were granted on December 22, 2023 under the 2024 eXponential Stock Plan, with performance for the fourth tranche certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the delivered shares will be subject to a minimum holding period. Following this award, Mak directly holds 13,755.968 shares of Axon common stock.
AXON ENTERPRISE, INC. reported that officer Elizabeth Reid Coughlin, Chief Human Officer, acquired 6,818 shares of common stock in the form of performance-based restricted stock units (XSUs). These units relate to a grant made on December 22, 2023, for which the fourth tranche’s performance conditions were certified as achieved on August 16, 2026. The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the shares will be subject to a minimum holding period extending to the earlier of December 31, 2030 or the vesting of a subsequent tranche. Following this acquisition, Coughlin holds 40,841.833 shares of Axon common stock directly.
AXON ENTERPRISE, INC. reported that Chief Legal Officer Isaiah Fields acquired 10,488 shares of common stock via vesting of performance-based restricted stock units (XSUs). These units were originally granted on December 22, 2023 under the 2024 eXponential Stock Plan after the Compensation Committee certified performance for the fourth tranche on August 16, 2026.
The tranche is scheduled to vest on December 1, 2026, subject to continued employment, and the resulting shares are subject to a minimum holding period until the earlier of December 31, 2030 or a subsequent tranche vesting, excluding any shares withheld or sold for taxes. Following this award, Fields directly holds 58,044.014 shares of Axon common stock.
AXON ENTERPRISE, INC. reported that Chief Revenue Officer Cameron Brooks acquired 15,810 shares of common stock through the certification of performance-based restricted stock units (XSUs) under the 2024 eXponential Stock Plan. These units relate to the fourth tranche, whose performance conditions were certified as met on August 16, 2026. The tranche is scheduled to vest on April 1, 2027, subject to continued employment, and the resulting shares will be subject to a minimum holding period until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding any shares withheld or sold for taxes. Following this award, Brooks holds 67,980.933 shares of Axon common stock directly.
AXON ENTERPRISE, INC. reported that CEO and director Patrick W. Smith acquired 97,015 shares of Common Stock through performance-based restricted stock units tied to the fourth tranche of the 2024 CEO Performance Award. The Compensation Committee certified the performance conditions on August 16, 2026, resulting in this grant. Following the award, Smith directly holds 3,128,012 shares. These units will vest on December 31, 2029, subject to continued employment, and vested shares are subject to a minimum holding period extending until the earlier of December 31, 2030 or the vesting of a subsequent tranche, excluding any shares withheld for taxes.
Axon Enterprise, Inc. director and chief executive officer Patrick W. Smith reported a sale of 70 shares of common stock on August 7, 2026 at a weighted average price of $566.6186 per share, executed under a Rule 10b5-1 trading plan adopted on May 12, 2025. Following this transaction, he held 3,030,997 shares of Axon common stock directly.
AXON ENTERPRISE, INC. chief executive officer Patrick W. Smith reported open-market sales of a total of 9,930 shares of common stock on August 7, 2026. The 30 transactions were executed at per-share prices ranging from $526.5195 to $565.6468 pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 12, 2025.
Isner Joshua reported acquisition or exercise transactions in this Form 4 filing.
Axon Enterprise, Inc. reported that its president, Joshua Isner, received a grant of 78,200 service-based restricted stock units of common stock on 2026-08-05 under the Amended and Restated 2022 Stock Incentive Plan. The units vest in 12 equal quarterly installments from November 13, 2026 through August 13, 2029, leaving him with 247,324.629 shares directly owned after the grant.
Bagley Brittany reported acquisition or exercise transactions in this Form 4 filing.
Axon Enterprise, Inc. granted 22,749 shares of common stock in the form of service-based restricted stock units to COO & CFO Brittany Bagley under its Amended and Restated 2022 Stock Incentive Plan. The award covers the twelve-quarter period from the third quarter of 2026 through the third quarter of 2029 and vests in twelve substantially equal quarterly installments from November 13, 2026 to August 13, 2029. Following this grant, Bagley directly holds 99,833.479 shares of Axon common stock.
Kunins Jeffrey C reported acquisition or exercise transactions in this Form 4 filing.
Axon Enterprise, Inc. granted CPO & CTO Jeffrey C. Kunins 29,531 restricted stock units under the Amended and Restated 2022 Stock Incentive Plan. The service-based award is part of a three-year executive program and vests in 12 equal quarterly installments from November 13, 2026 through August 13, 2029. After this grant, Kunins is reported as directly holding 89,227.817 shares and indirectly holding 86,268 shares through an LLC.
Brooks Cameron reported acquisition or exercise transactions in this Form 4 filing.
Axon Enterprise chief revenue officer Cameron Brooks received a grant of 2,461 restricted stock units of common stock, increasing his direct holdings to 52,170.933 shares. The award is part of a three-year executive compensation program targeting $3.3 million in RSU value and vests in seven quarterly installments from February 13, 2028 through August 13, 2029.
Kant Eiso Hendricus Roland Leon reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Eiso Hendricus Roland Leon Kant reported a grant of 600 shares of Common Stock in the form of time-vested restricted stock units under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. These units are scheduled to vest in three equal installments beginning on July 8, 2027. Following this award, the reporting person holds 3,165 shares of Common Stock directly.
MOHINDRA VIVEK reported acquisition or exercise transactions in this Form 4 filing.
Axon Enterprise, Inc. director Vivek Mohindra reported an equity compensation grant of 600 shares of common stock through time-vested restricted stock units under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award was granted at $0.00 per share and is scheduled to vest in three equal installments beginning on July 8, 2027, subject to the plan’s terms.
Axon Enterprise CEO Patrick W. Smith reported selling 10,000 shares of common stock in open-market transactions. The trades occurred on July 7, 2026 under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
The sales were broken into multiple small trades, including executions at $628.2000 and $662.6950 per share. After these transactions, Smith directly holds 3,040,997 shares of Axon common stock, indicating he retains a very large equity position in the company.
Axon Enterprise CEO Patrick W. Smith reported an open-market sale of 10,000 shares of common stock at a weighted average price of $500.0018 per share on the reported transaction date. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
Following this transaction, Smith directly holds 3,050,997 shares of Axon Enterprise common stock. The sale was carried out in multiple trades within a price range of $500.00 to $500.18, with the reported price reflecting the weighted average.
Axon Enterprise, Inc. President Joshua Isner reported open-market sales of 13,000 shares of common stock on June 5, 2026. The Form 4 shows 19 separate sale transactions classified as non-derivative common stock sales. Reported sale prices span a range from approximately $481.48 to $501.32 per share, reflecting multiple trades during the day.
Following these transactions, Isner directly holds about 169,124.629 shares of Axon common stock. The filing does not show any related option exercises or derivative security activity, indicating these were straightforward open-market sales from existing share holdings.
AXON ENTERPRISE, INC. executive Elizabeth Reid Coughlin, the company’s Chief Human Officer, reported an open-market sale of Common Stock. She sold 1,554 shares at a price of $485.00 per share. After this transaction, she directly holds 34,023.833 shares of Axon stock, indicating she retained a substantial remaining stake.
Axon Enterprise, Inc. chief revenue officer Cameron Brooks reported an open-market sale of Common Stock. On June 4, 2026, he sold 1,242 shares at a price of $500.00 per share. Following this transaction, he directly holds 49,709.933 shares of Axon Common Stock.
According to a footnote, this sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.
AXON ENTERPRISE, INC. chief executive officer Patrick W. Smith reported an open-market sale of 20,000 shares of common stock at $500.00 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025. Following this sale, Smith directly holds 3,060,997 shares of Axon common stock.
AXON ENTERPRISE, INC. Chief Accounting Officer Jennifer H. Mak reported two transactions in common stock tied to tax withholding. On June 1, 2026, a total of about 2,223.9 shares were disposed of to cover tax liabilities from the vesting of restricted stock units under Axon’s equity plans. These are administrative, non–open-market dispositions and do not represent discretionary share sales.
AXON ENTERPRISE, INC. Chief Product & Technology Officer Jeffrey C. Kunins reported a routine tax-related share withholding tied to vesting of performance-based restricted stock units. On June 1, 2026, 8,113.183 shares of common stock at $476.88 per share were disposed of to settle his tax liability from the vesting of the third tranche of RSUs granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
Following this tax-withholding disposition, Kunins directly held 59,696.817 shares of Axon common stock. Separately, he indirectly owned 86,268 shares through an LLC of which he is the sole member. The Form 4 does not show any open-market purchases or sales, only the tax withholding and updated holdings.
AXON ENTERPRISE, INC. COO & CFO Brittany Bagley reported an open-market sale of 5,969 shares of common stock on June 2, 2026 at $485.00 per share. After this transaction, she directly owned 77,084.479 shares of Axon common stock.
On June 1, 2026, 16,181.521 shares were disposed of at $476.88 per share to cover her tax liability from the vesting of the third tranche of restricted stock units granted under Axon’s 2024 eXponential Stock Plan, which is a tax-withholding event rather than an open-market sale.
Axon Enterprise president Joshua Isner reported a tax-withholding disposition of common stock tied to vesting restricted stock units. On this event, 32,796.371 shares of common stock were withheld at $476.8800 per share to settle his tax liability from the vesting of the third tranche of RSUs.
These RSUs were granted under the Axon Enterprise, Inc. 2024 eXponential Stock Plan, after performance conditions were certified by the company’s Compensation Committee on November 13, 2025. Following the tax withholding, Isner directly holds 182,124.629 shares of Axon common stock. This disposition reflects tax settlement and is not an open-market trade.
AXON ENTERPRISE, INC. executive Elizabeth Reid Coughlin, the company’s Chief Human Officer, reported two tax-withholding dispositions of common stock tied to restricted stock unit vesting. A total of 3,401.209 shares were withheld to cover her tax liabilities upon vesting, including performance-based awards under Axon’s 2024 eXponential Stock Plan. These were not open-market sales, but shares retained by the issuer for taxes. Following these dispositions, she directly holds 35,577.833 shares of Axon common stock.
AXON ENTERPRISE, INC. chief revenue officer Cameron Brooks reported a routine share disposition tied to taxes rather than a market trade. On June 1, 2026, 743.757 shares of common stock were withheld at $448.72 per share to cover tax liability from vesting restricted stock units. Following this tax-withholding event, Brooks directly holds 50,951.933 shares of Axon common stock.
Axon Enterprise Chief Legal Officer Isaiah Fields reported routine share dispositions related to tax withholding. On June 1, 2026, a total of 5,257.268 shares of common stock were disposed of at prices of $476.88 and $448.72 per share to settle tax liabilities from the vesting of restricted stock units, including awards under the Axon Enterprise, Inc. 2024 eXponential Stock Plan.
AXON ENTERPRISE, INC. director Jeri Williams reported a mix of stock award and sales. On May 29, 2026, she received 611 time-vested restricted stock units under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual Meeting of Shareholders.
On June 1, 2026, she completed two open-market sales totaling 629 shares of common stock: 223 shares at $455.45 per share and 406 shares at a weighted average price of $477.4333 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. Following these transactions, she directly holds 1,141 shares of Axon common stock.
AXON ENTERPRISE, INC. director Caitlin Elizabeth Kalinowski reported mixed equity activity. On June 1, 2026, she completed a series of open-market sales totaling 564 shares of Axon common stock at prices including $484.11 and $473.32 per share, leaving her with 3,632 shares held directly. Earlier, on May 29, 2026, she received a grant of 611 time-vested restricted stock units under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 annual meeting of shareholders.
SMITH GRAHAM reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Graham Smith received an equity award of 611 shares of Common Stock as a grant under the company’s stock incentive plan. This award is in the form of time-vested restricted stock units that vest in full on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Shareholders. Following this grant, Smith directly holds 3,629 shares of Axon common stock. The transaction reflects routine equity compensation rather than an open-market purchase or sale.
Partovi Hadi reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Hadi Partovi reported receiving a grant of 611 shares of common stock in the form of time-vested restricted stock units at a price of $0.00 per share. These units were granted under Axon’s Amended and Restated 2022 Stock Incentive Plan and are scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon’s 2027 Annual Meeting of Shareholders. Following this award, Partovi directly holds 238,649 shares of Axon common stock.
Morgenfeld Todd R reported acquisition or exercise transactions in this Form 4 filing.
Axon Enterprise director Todd R. Morgenfeld received an equity grant of 611 shares of Common Stock in the form of time-vested restricted stock units. The units were granted at no cash cost and increase his direct holdings to 947 shares. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.
GARNREITER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Michael Garnreiter reported equity compensation awards rather than open-market trades. On May 29, 2026, he received two grants of common stock totaling several hundred shares at $0.00 per share as part of his director compensation. A footnote explains these are time-vested restricted stock units granted under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual Meeting of Shareholders. These transactions reflect routine, plan-based stock awards instead of discretionary buying or selling of Axon shares.
Brown Adriane M reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Adriane M. Brown received an equity grant of 611 shares of Common Stock on May 29, 2026 as a compensation award. The shares are in the form of time-vested restricted stock units granted under the company’s Amended and Restated 2022 Stock Incentive Plan.
The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders. Following this grant, Brown directly holds 8,437 shares of Axon common stock, indicating a relatively small, routine director equity award rather than an open-market transaction.
Nardini Erika reported acquisition or exercise transactions in this Form 4 filing.
AXON ENTERPRISE, INC. director Erika Nardini received an equity grant of 611 shares of Common Stock through time-vested restricted stock units. The award was granted at no cash cost to her and increased her direct holdings to 2,557 shares of Axon common stock.
The restricted stock units were granted under Axon’s Amended and Restated 2022 Stock Incentive Plan and are scheduled to vest in full on the earlier of the one-year anniversary of the May 29, 2026 grant date and the date of Axon’s 2027 Annual Meeting of Shareholders.
AXON ENTERPRISE, INC. Chief Legal Officer Isaiah Fields reported an open-market sale of 2,000 shares of Common Stock on 2026-05-22 at a price of $400.00 per share. After this transaction, he directly holds 52,813.282 shares, indicating he retained a substantial position in the company.
Axon Enterprise CHIEF REVENUE OFFICER Cameron Brooks reported a routine share withholding tied to equity compensation. On the transaction date, 5,849.7 shares of Common Stock were disposed of to cover tax obligations from the vesting of restricted stock units.
These shares were withheld rather than sold in the open market, reflecting a tax-withholding disposition under the company’s 2024 eXponential Stock Plan. After this event, Brooks directly held 51,695.69 shares of Axon common stock, as reported in the filing.
Axon Enterprise director Jeri Williams reported an open-market sale of common stock. On March 17, 2026, Williams sold 157 shares at a price of $490.00 per share. After the sale, Williams directly owned 1,159 shares of Axon common stock. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating it was scheduled in advance rather than timed discretionarily.
Axon Enterprise director Erika Nardini sold shares in an open-market trade. On March 17, 2026, she sold 198 shares of common stock at an average price of $506.579 per share. After this transaction, she directly holds 1,946 Axon common shares.
Axon Enterprise president Joshua Isner reported a series of open-market stock sales. On March 10, he sold a total of 34,581 shares of Axon common stock in 18 separate transactions, at prices generally in the low-to-mid $500s per share. After these sales, he continued to hold 214,921 shares directly, so he remains a significant shareholder. The filing notes that many trades were executed in multiple lots, with reported prices representing weighted averages within specified intraday price ranges.
Axon Enterprise CEO Patrick W. Smith reported selling 10,000 shares of common stock in multiple open-market transactions on March 9, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2025.
The trades were priced at reported weighted-average prices ranging from about $546.81 to $577.12 per share. After these transactions, Smith continues to hold 3,080,997 shares of Axon Enterprise common stock directly, indicating that the sale represents a small portion of his overall stake.
Axon Enterprise's Chief Revenue Officer, Cameron Brooks, reported an open-market sale of 1,221 shares of common stock. The shares were sold at an average price of $565.51 per share. After this transaction, Brooks directly holds about 57,545 shares, so the sale represents a small portion of his overall position. According to a footnote, the trade was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025, indicating it was scheduled in advance rather than timed opportunistically.